Evotec and Sernova enter into a worldwide exclusive strategic partnership in the field of iPSC-based beta cell replacement therapy to develop a funjtional cure for diabetes.
I do not guarantee the completeness and/or accuracy of the news.
This is not an analgeberatung, investment recommendation or a call to action.